The American Society of Clinical Oncology (ASCO) is a medical professional oncology society committed to conquering cancer through research, education, prevention, and delivery of high-quality patient ...

Sign in to explore collection of abstracts, journal articles, posters, videos, and slides.

Sequential immunotherapy in rare variant renal cell carcinomafinal report of UNISoN (ANZUP 1602): Nivolumab then ipilimumab + nivolumab in advanced nonclear cell renal cell carcinoma. - ASCO Home / ...

Prospective ctDNA genotyping for treatment selection in metastatic castration-resistant prostate cancer (mCRPC): The Canadian Cancer Trials Group phase II PC-BETS umbrella study. - ASCO Home / Posters ...

Sign in to explore collection of abstracts, journal articles, posters, videos, and slides.

Sign in to explore collection of abstracts, journal articles, posters, videos, and slides.

Sign in to explore collection of abstracts, journal articles, posters, videos, and slides.

Phase II single-arm study of palbociclib and cetuximab rechallenge in KRAS/NRAS/BRAF wild-type (KRAS WT) metastatic colorectal cancer (mCRC) patients (pts).

Ten-year overall and prostate cancer (PCa)-specific mortality in high-risk patients after high-dose-rate brachytherapy combined with external beam radiation therapy (HDR-BT/EBRT) compared with EBRT ...

COMBAT: A study of ⁶⁴Cu-SAR-BBN and ⁶⁷Cu-SAR-BBN for identification and treatment of GRPr-expressing metastatic castrate-resistant prostate cancer. - ASCO Home / Posters / ...

Sign in to explore collection of abstracts, journal articles, posters, videos, and slides.

Sign in to explore collection of abstracts, journal articles, posters, videos, and slides.